Investors may be skeptical about the company's ability to ma...
Investors may be skeptical about the company's ability to maintain strong revenue performance, despite its forecasted growth being higher than its industry. This could explain the significantly depressed P/S ratio.
Potential Upside For Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972) Not Without Risk
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment